Int J Angiol 2020; 29(02): 065-071
DOI: 10.1055/s-0040-1705153
Invited Articles
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Etiology, Pathology, and Classification of Atrial Fibrillation

Srishti Nayak
1   Loma Linda University School of Medicine, Loma Linda, California
,
Balaji Natarajan
2   University of California, Riverside School of Medicine, Riverside, California
,
Ramdas G. Pai
2   University of California, Riverside School of Medicine, Riverside, California
› Author Affiliations
Further Information

Publication History

Publication Date:
29 March 2020 (online)

Abstract

Atrial fibrillation (AF) is a disorganized tachyarrhythmia with significant public health importance due to high morbidity, mortality, and health-care costs. Incidence rate of AF is on the rise and there are several modifiable and nonmodifiable risk factors that are responsible. Exact mechanisms and pathogenesis of AF are still poorly understood, yet they still have great implications in management. The aim of this article is to summarize the epidemiology, major risk factors, and their role in the pathogenesis of AF. Finally, we have reviewed the classification of AF as per professional society guidelines.

 
  • References

  • 1 Zipes DP, Libby P, Bonow RO, Mann DL, Tomaselli GF. Braunwald's Heart Disease E-Book: A Textbook of Cardiovascular Medicine. Philadelphia: Elsevier Health Sciences; 2018
  • 2 Benjamin EJ, Muntner P, Alonso A. , et al; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2019 Update: a report from the American Heart Association. Circulation 2019; 139 (10) e56-e528
  • 3 Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994; 271 (11) 840-844
  • 4 Wakili R, Voigt N, Kääb S, Dobrev D, Nattel S. Recent advances in the molecular pathophysiology of atrial fibrillation. J Clin Invest 2011; 121 (08) 2955-2968
  • 5 Miller JD, Aronis KN, Chrispin J. , et al. Obesity, exercise, obstructive sleep apnea, and modifiable atherosclerotic cardiovascular disease risk factors in atrial fibrillation. J Am Coll Cardiol 2015; 66 (25) 2899-2906
  • 6 Lau DH, Nattel S, Kalman JM, Sanders P. Modifiable risk factors and atrial fibrillation. Circulation 2017; 136 (06) 583-596
  • 7 Lazzerini PE, Capecchi PL, Laghi-Pasini F. Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis. Eur Heart J 2017; 38 (22) 1717-1727
  • 8 Huxley RR, Lopez FL, Folsom AR. , et al. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2011; 123 (14) 1501-1508
  • 9 Middeldorp ME, Ariyaratnam J, Lau D. , et al. Lifestyle modifications for treatment of atrial fibrillation. Heart 2020; 106 (05) 325-332
  • 10 Pierdomenico SD, Lapenna D, Cuccurullo F. Risk of atrial fibrillation in dipper and nondipper sustained hypertensive patients. Blood Press Monit 2008; 13 (04) 193-197
  • 11 Verdecchia P, Angeli F, Reboldi G. Hypertension and atrial fibrillation: doubts and certainties from basic and clinical studies. Circ Res 2018; 122 (02) 352-368
  • 12 Wang A, Green JB, Halperin JL, Piccini Sr JP. Atrial fibrillation and diabetes mellitus: JACC review topic of the week. J Am Coll Cardiol 2019; 74 (08) 1107-1115
  • 13 Echouffo-Tcheugui JB, Shrader P, Thomas L. , et al. Care patterns and outcomes in atrial fibrillation patients with and without diabetes: ORBIT-AF Registry. J Am Coll Cardiol 2017; 70 (11) 1325-1335
  • 14 Saito S, Teshima Y, Fukui A. , et al. Glucose fluctuations increase the incidence of atrial fibrillation in diabetic rats. Cardiovasc Res 2014; 104 (01) 5-14
  • 15 Gómez-Outes A, Lagunar-Ruíz J, Terleira-Fernández AI, Calvo-Rojas G, Suárez-Gea ML, Vargas-Castrillón E. Causes of death in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol 2016; 68 (23) 2508-2521
  • 16 Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 2003; 91 (6A, 6a): 2D-8D
  • 17 Wang TJ, Larson MG, Levy D. , et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 2003; 107 (23) 2920-2925
  • 18 Zafrir B, Lund LH, Laroche C. , et al. Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry. Eur Heart J 2018; 39 (48) 4277-4284
  • 19 Thihalolipavan S, Morin DP. Atrial fibrillation and congestive heart failure. Heart Fail Clin 2014; 10 (02) 305-318
  • 20 Mayyas F, Niebauer M, Zurick A. , et al. Association of left atrial endothelin-1 with atrial rhythm, size, and fibrosis in patients with structural heart disease. Circ Arrhythm Electrophysiol 2010; 3 (04) 369-379
  • 21 Balcioğlu AS, Çiçek D, Akinci S. , et al. Arrhythmogenic evidence for epicardial adipose tissue: heart rate variability and turbulence are influenced by epicardial fat thickness. Pacing Clin Electrophysiol 2015; 38 (01) 99-106
  • 22 Pathak RK, Middeldorp ME, Meredith M. , et al. Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY). J Am Coll Cardiol 2015; 65 (20) 2159-2169
  • 23 January CT, Wann LS, Calkins H. , et al; Writing Group Members. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm 2019; 16 (08) e66-e93
  • 24 January CT, Wann LS, Calkins H. , et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons. Circulation 2019; 140 (02) e125-e151
  • 25 Kanagala R, Murali NS, Friedman PA. , et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003; 107 (20) 2589-2594
  • 26 Fein AS, Shvilkin A, Shah D. , et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol 2013; 62 (04) 300-305
  • 27 Mora S, Akinkuolie AO, Sandhu RK, Conen D, Albert CM. Paradoxical association of lipoprotein measures with incident atrial fibrillation. Circ Arrhythm Electrophysiol 2014; 7 (04) 612-619
  • 28 Lopez FL, Agarwal SK, Maclehose RF. , et al. Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: the atherosclerosis risk in communities study. Circ Arrhythm Electrophysiol 2012; 5 (01) 155-162
  • 29 Alonso A, Yin X, Roetker NS. , et al. Blood lipids and the incidence of atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis and the Framingham Heart Study. J Am Heart Assoc 2014; 3 (05) e001211
  • 30 Fauchier L, Clementy N, Babuty D. Statin therapy and atrial fibrillation: systematic review and updated meta-analysis of published randomized controlled trials. Curr Opin Cardiol 2013; 28 (01) 7-18
  • 31 Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest 2007; 131 (05) 1557-1566
  • 32 Goette A, Lendeckel U, Kuchenbecker A. , et al. Cigarette smoking induces atrial fibrosis in humans via nicotine. Heart 2007; 93 (09) 1056-1063
  • 33 Chamberlain AM, Agarwal SK, Folsom AR. , et al. Smoking and incidence of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) study. Heart Rhythm 2011; 8 (08) 1160-1166
  • 34 Du X, Dong J, Ma C. Is atrial fibrillation a preventable disease?. J Am Coll Cardiol 2017; 69 (15) 1968-1982
  • 35 Conen D, Tedrow UB, Cook NR, Moorthy MV, Buring JE, Albert CM. Alcohol consumption and risk of incident atrial fibrillation in women. JAMA 2008; 300 (21) 2489-2496
  • 36 Mozaffarian D, Furberg CD, Psaty BM, Siscovick D. Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study. Circulation 2008; 118 (08) 800-807
  • 37 Qureshi WT, Alirhayim Z, Blaha MJ. , et al. Cardiorespiratory fitness and risk of incident atrial fibrillation: results from the Henry Ford Exercise Testing (FIT) project. Circulation 2015; 131 (21) 1827-1834
  • 38 Elliott AD, Mahajan R, Lau DH, Sanders P. Atrial fibrillation in endurance athletes: from mechanism to management. Cardiol Clin 2016; 34 (04) 567-578
  • 39 Khan H, Kella D, Rauramaa R, Savonen K, Lloyd MS, Laukkanen JA. Cardiorespiratory fitness and atrial fibrillation: a population-based follow-up study. Heart Rhythm 2015; 12 (07) 1424-1430
  • 40 Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001; 344 (07) 501-509
  • 41 Bielecka-Dabrowa A, Mikhailidis DP, Rysz J, Banach M. The mechanisms of atrial fibrillation in hyperthyroidism. Thyroid Res 2009; 2 (01) 4
  • 42 Narayan SM, Krummen DE, Shivkumar K, Clopton P, Rappel WJ, Miller JM. Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. J Am Coll Cardiol 2012; 60 (07) 628-636
  • 43 Hansen BJ, Csepe TA, Zhao J, Ignozzi AJ, Hummel JD, Fedorov VV. Maintenance of atrial fibrillation: are reentrant drivers with spatial stability the key?. Circ Arrhythm Electrophysiol 2016; 9 (10) e004398
  • 44 Santangeli P, Marchlinski FE. Techniques for the provocation, localization, and ablation of non-pulmonary vein triggers for atrial fibrillation. Heart Rhythm 2017; 14 (07) 1087-1096
  • 45 Iwasaki YK, Nishida K, Kato T, Nattel S. Atrial fibrillation pathophysiology: implications for management. Circulation 2011; 124 (20) 2264-2274
  • 46 Lau DH, Linz D, Schotten U, Mahajan R, Sanders P, Kalman JM. Pathophysiology of paroxysmal and persistent atrial fibrillation: rotors, foci and fibrosis. Heart Lung Circ 2017; 26 (09) 887-893
  • 47 January CT, Wann LS, Alpert JS. , et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014; 64 (21) e1-e76
  • 48 Kirchhof P, Benussi S, Kotecha D. , et al; ESC Scientific Document Group. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016; 37 (38) 2893-2962